Lung cancer

Room to improve care for stage lll NSCLC

The lung cancer multidisciplinary team (MDT) is critical to best practice and better outcomes in patients with stage lll non-small cell lung cancer (NSCLC). However, according to a review article in the Asia-Pacific Journal of Clinical Oncology, only about half of patients are receiving this level of care in Australia. “Patients with stage III NSCLC ...

Already a member?

Login to keep reading.

© 2021 the limbic